Research graph
References from Altered striatal acetylcholine dynamics in a model of Parkinson's disease and L-DOPA-induced dyskinesia. Local targets link to admitted publications; unresolved targets remain external evidence.
Key role of striatal cholinergic interneurons in processes leading to arrest of motor stereotypies
10.1093/brain/awq285 · 2011 · External reference
Acetylcholine-dopamine balance hypothesis in the striatum: an update
2010 · External reference
Levodopa disrupts activity patterns and encoding of movement in striatal cholinergic interneurons of behaving mice
10.1002/mds.70018 · 2025 · External reference
The pathogenesis of Parkinson’s disease: a new hypothesis
1962 · External reference
Optogenetic activation of striatal cholinergic interneurons regulates L-dopa-induced dyskinesias
10.1016/j.nbd.2016.02.019 · 2016 · External reference
Publisher correction: the dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia
10.1038/s41598-020-61832-3 · 2020 · External reference
The dopamine D5 receptor contributes to activation of cholinergic interneurons during L-DOPA induced dyskinesia
10.1038/s41598-020-59011-5 · 2020 · External reference
Effects of muscarinic acetylcholine m1 and m4 receptor blockade on dyskinesia in the hemi-parkinsonian rat
10.1016/j.neuroscience.2019.04.008 · 2019 · External reference
Alterations in the intrinsic properties of striatal cholinergic interneurons after dopamine lesion and chronic L-DOPA
2020 · External reference
Quinpirole inhibits levodopa-induced dyskinesias at structural and behavioral levels: efficacy negated by co-administration of isradipine
10.1016/j.expneurol.2023.114522 · 2023 · External reference
A new outlook on cholinergic interneurons in Parkinson’s disease and L-DOPA-induced dyskinesia
10.1016/j.neubiorev.2018.05.021 · 2018 · External reference
Involvement of I(h) in dopamine modulation of tonic firing in striatal cholinergic interneurons
10.1523/jneurosci.5535-06.2007 · 2007 · External reference
RGS4-dependent attenuation of M4 autoreceptor function in striatal cholinergic interneurons following dopamine depletion
10.1038/nn1700 · 2006 · External reference
Enhanced striatal cholinergic neuronal activity mediates L-DOPA-induced dyskinesia in parkinsonian mice
10.1073/pnas.1006511108 · 2011 · External reference
Differential activation states of direct pathway striatal output neurons during l-DOPA-induced dyskinesia development
10.1523/jneurosci.0050-24.2024 · 2024 · External reference
Effects of acute dopamine depletion on the electrophysiological properties of striatal neurons
10.1016/j.neures.2007.04.002 · 2007 · External reference
An optimized acetylcholine sensor for monitoring in vivo cholinergic activity
10.1038/s41592-020-0953-2 · 2020 · External reference
Intrinsic dopamine and acetylcholine dynamics in the striatum of mice
10.1038/s41586-023-05995-9 · 2023 · External reference
Accumbal dopamine and acetylcholine dynamics during psychostimulant sensitization
2025 · External reference
Striatal cholinergic interneuron regulation and circuit effects
10.3389/fnsyn.2014.00022 · 2014 · External reference
Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia
10.1016/j.expneurol.2005.02.002 · 2005 · External reference
Rhythmicity of neuronal oscillations delineates their cortical and spectral architecture
10.1038/s42003-024-06083-y · 2024 · External reference
Levodopa causes striatal cholinergic interneuron burst-pause activity in Parkinsonian mice
10.1002/mds.28516 · 2021 · External reference
The striatal cholinergic system in L-dopa-induced dyskinesias
10.1007/s00702-018-1845-9 · 2018 · External reference
Re-emergence of striatal cholinergic interneurons in movement disorders
10.1016/j.tins.2007.07.008 · 2007 · External reference
Striatal cholinergic transmission in an inducible transgenic mouse model of paroxysmal non-kinesiogenic dyskinesia
10.1016/j.nbd.2024.106685 · 2024 · External reference
Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists
10.1016/j.nbd.2016.09.001 · 2016 · External reference
M4 muscarinic receptor signaling ameliorates striatal plasticity deficits in models of L-DOPA-induced dyskinesia
10.1016/j.neuron.2015.10.039 · 2015 · External reference
Striatal cholinergic interneuron membrane voltage tracks locomotor rhythms in mice
10.1038/s41467-023-39497-z · 2023 · External reference
Dopamine induced switch in the subthreshold dynamics of the striatal cholinergic interneurons: a numerical study
10.1016/j.jtbi.2008.09.029 · 2009 · External reference
Striatal cholinergic interneurons and Parkinson’s disease
10.1111/ejn.13638 · 2018 · External reference
Striatal cholinergic interneuron pause response requires Kv1 channels, is absent in dyskinetic mice, and is restored by dopamine D5 receptor inverse agonism
10.7554/elife.102184.4 · 2025 · External reference
Dopamine 2 receptor ablation from cholinergic neurons attenuates L-DOPA induced dyskinesias
10.3389/fnagi.2026.1779861 · 2026 · External reference
Striatal cholinergic cell ablation attenuates L-DOPA induced dyskinesia in parkinsonian mice
10.1523/jneurosci.2888-13.2014 · 2014 · External reference
State-dependent modulation of spiny projection neurons controls levodopa-induced dyskinesia in a mouse model of Parkinson’s disease
10.1126/sciadv.adv8224 · 2025 · External reference
Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson’s disease
10.1016/j.neuint.2019.02.019 · 2019 · External reference
Involvement of striatal cholinergic interneurons and M1 and M4 muscarinic receptors in motor symptoms of Parkinson’s disease
10.1523/jneurosci.0873-16.2016 · 2016 · External reference
